Evidence map›Paper›PMID 19303767›Full record

ReviewCurrent opinion in structural biology2009

The long and the short of riboswitches.

Alexander Serganov

Abstract readReview
In one paragraph

Review in Current opinion in structural biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Riboswitch diversity and distribution.RNA (New York, N.Y.) · 2017
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. RNA quaternary structure and global symmetry.Trends in biochemical sciences · 2015
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. RNA modularity for synthetic biology.F1000prime reports · 2013
    Review
  18. Article
  19. Molecular recognition and function of riboswitches.Current opinion in structural biology · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alexander SerganovStructural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. serganoa@mskcc.org

Funding

RNA REGULATORY DOMAINS: FOLDING, RECOGNITION &CATALYSISR01GM073618 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PATEL, DINSHAW J · 2005 to 2008
$1.3M
NIGMS NIH HHS GM073618NIGMS NIH HHS R01 GM073618
6 · The paper itself

Abstract

Regulatory mRNA elements or riboswitches specifically control the expression of a large number of genes in response to various cellular metabolites. The basis for selectivity of regulation is programmed in the evolutionarily conserved metabolite-sensing regions of riboswitches, which display a plethora of sequence and structural variants. Recent X-ray structures of two distinct SAM riboswitches and the sensing domains of the Mg(2+), lysine, and FMN riboswitches have uncovered novel recognition principles and provided molecular details underlying the exquisite specificity of metabolite binding by RNA. These and earlier structures constitute the majority of widespread riboswitch classes and, together with riboswitch folding studies, improve our understanding of the mechanistic principles involved in riboswitch-mediated gene expression control.

Indexed as

Gene Expression RegulationLigandsModels, MolecularNucleic Acid ConformationRNA, MessengerSubstrate SpecificityLigandsRNA, Messenger

Identifiers

PMID19303767
PMCPMC2762789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.